Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study

J Thromb Haemost. 2012 Jun;10(6):1177-9. doi: 10.1111/j.1538-7836.2012.04703.x.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Case-Control Studies
  • Citalopram / therapeutic use*
  • Down-Regulation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Netherlands
  • P-Selectin / metabolism
  • Paroxetine / therapeutic use*
  • Platelet Function Tests
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Serotonin / metabolism

Substances

  • Antidepressive Agents, Second-Generation
  • P-Selectin
  • SELP protein, human
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Serotonin
  • Paroxetine